Santarus Defends Zegerid Patents In Fed. Circ.
Santarus Inc. sought to convince the Federal Circuit on Monday that not only were patents it licensed for heartburn drug Zegerid not obvious, as a district court ruled, but that prior...To view the full article, register now.
Already a subscriber? Click here to view full article